F
$ Value
$236K
Shares
3,262
Price
$72
Filed
Apr 2
Insider
Name
Clark James David
Title
SVP, Cont & Chief Acct Officer
CIK
0001757584
Roles
Officer
Transaction Details
Transaction Date
2026-04-01
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
15,457
Footnotes
Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. | Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. | Option becomes exercisable in three equal annual installments, commencing 3/31/2027.
Filing Info
Clark James David's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | CVS | F | $236K |
| 2026-03-31 | CVS | A | $800K |
| 2026-03-31 | CVS | A | $860K |
| 2025-12-01 | CVS | F | $17K |
Other Insiders at CVS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Nelson Steven H
EVP and President, Aetna
|
$1K | — | 2026-04-01 |
|
Joyner J. David
President, CEO and Chair
|
— | — | 2026-04-01 |
|
Khichi Samrat S.
EVP, CPO and General Counsel
|
— | — | 2026-04-01 |
|
CAPOZZI HEIDI B
EVP and Chief People Officer
|
— | — | 2026-04-01 |
|
Compton-Phillips Amy
EVP, Chief Medical Officer
|
— | — | 2026-03-31 |
|
Clark James David
SVP, Cont & Chief Acct Officer
|
— | — | 2026-03-31 |
|
Newman Brian
EVP, Chief Financial Officer
|
— | — | 2026-03-31 |
|
Mandadi Tilak
EVP, Chief Exp & Tech Officer
|
— | — | 2026-04-01 |
|
Shah Prem S
EVP and Group President
|
— | — | 2026-04-01 |